Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

Clinical trial NCT01061606 · TERMINATED

Trial details

NCT number: NCT01061606
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Sarcoma Uterine Carcinosarcoma

Start date: 2010-01-01
Primary completion: 2012-04-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.